Surrogate Endpoints Show Mixed Value in Breast Cancer Trials
Individual patient data from neoadjuvant randomized breast cancer clinical trials with available data on pathologic complete response, invasive disease-free survival, and overall survival were analyzed.
đ Full Story
Statins only add 3 DAYS to your life?!?
- Unravel the Midwinter Blight in the Fractured Peaks (Diablo IV) - Michael A. Medeiros
- The Misconceptions About Blue-Light Glasses: A Comprehensive Study - Arya Chandran
- Google Launches $10 Million Cybersecurity Program in Europe - Rob Wang
- Blockbuster Fantasy Prequel Free On Tubi Controversial For Classic Fans - Chris Snellgrove
- How to watch Super Bowl 2025 for free: Chiefs vs. Eagles on Sunday, February 9 - Liz Kocan
- The Depressing Reason Netflix Ruined The Best Horror Comedy Series In Years - Jonathan Klotz
Migrant Rioters DEMAND To Stay In America
- âGood Night, And Good Luckâ Cast Set For George Clooney Broadway Debut: Ilana Glazer, Clark Gregg, Many Others - Greg Evans
- High school students get insider look at medicine during âChat With a Docâ event - Jerry.Grimes@ecuhealth.org
- IKEAâs Smart Home Revolution: Introducing Remote Home Monitoring Sensors - Rob Wang
- Punxsutawney Phil: legendary groundhog, not-so-legendary forecasts, NOAA study reveals
- Republicans Should Support Workers â Not the Failed Union Model - F. Vincent Vernuccio
- Trump Restores âMaximum Pressureâ on Iran - Andrew Day